In a retrospective cohort study, ustekinumab and guselkumab show trends toward lower risk for herpes zoster in patients with ...

Researchers have determined in a new study that the recombinant zoster vaccine (RZV) offers good protection from herpes ...

To test it prospectively, GSK will work with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) ...

Shingles, or herpes zoster, is a viral infection caused by the varicella zoster virus, the same virus that causes chickenpox, ...

Shingles can be an extremely painful condition and complications can be long-lasting, particularly for older people and those ...

AIM Vaccine Co., Ltd. Class H ( ($HK:6660) ) has provided an update. AIM Vaccine Co., Ltd. has received approval from the U.S. FDA to conduct ...

Shingles can be an extremely painful condition and complications can be long-lasting, particularly for older people and those ...

Although measles is seen as a contagious viral disease that passes quickly, it can also cause damage that leaves long-term ...

The US Vaccines Market, (excluding COVID-19 vaccines), valued at US$25.98 billion in 2024, is forecasted to grow at a robust CAGR of 8.2%, ...

Shares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) have been assigned an average rating of “Hold” from the twenty-four ...

Moderna (NASDAQ:MRNA – Get Free Report) had its price objective lowered by analysts at JPMorgan Chase & Co. from $40.00 to ...

The post-approval safety profile of cladribine tablets in relapsing MS was updated, with results consistent with development ...